The up-regulation of CXCL2 could enhance the cell survival of lymphocytic leukemia (Burgess et al., 2012) and it was correlated with poor prognosis of bladder cancer (Zhang et al., 2016). Here, CXCL2 is linked to urinary bladder carcinoma.